购物车
- 全部删除
- 您的购物车当前为空
N-Desethyl Sunitinib(SU012662,N-去乙基-舒尼替) 是 Sunitinib 由细胞色素P450酶3A4 (CYP3A4)代谢产生的主要活性代谢物。Sunitinib是一种口服的抑制剂,可抑制多种酪氨酸激酶参与肿瘤增殖和血管生成,包括 VEGFR、PDGFR、KIT 和 FLT3 等,被批准用于治疗晚期/转移性肾细胞癌(RCC)
N-Desethyl Sunitinib(SU012662,N-去乙基-舒尼替) 是 Sunitinib 由细胞色素P450酶3A4 (CYP3A4)代谢产生的主要活性代谢物。Sunitinib是一种口服的抑制剂,可抑制多种酪氨酸激酶参与肿瘤增殖和血管生成,包括 VEGFR、PDGFR、KIT 和 FLT3 等,被批准用于治疗晚期/转移性肾细胞癌(RCC)
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 570 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,090 | 5日内发货 |
产品描述 | N-Desethyl Sunitinib (SU012662) is the primary active metabolite of Sunitinib produced by the metabolism of cytochrome P450 enzyme 3A4 (CYP3A4).Sunitinib is an orally available inhibitor of a number of tyrosine kinases involved in tumor proliferation and angiogenesis, including VEGFR, PDGFR, KIT, and FLT3, and was approved for the treatment of advanced/metastatic renal cell carcinoma (RCC) |
别名 | SU-11662, SU11662, N-去乙基-舒尼替 |
分子量 | 370.42 |
分子式 | C20H23FN4O2 |
CAS No. | 356068-97-8 |
Smiles | C(=C\1/C=2C(NC1=O)=CC=C(F)C2)\C3=C(C)C(C(NCCNCC)=O)=C(C)N3 |
密度 | 1.265 g/cm3 (Predicted) |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 4 mg/mL (10.8 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
评论内容